Vimab Group AB (FRA:NM4) Common Stock: €0.88 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:NM4 Vimab Group AB FRA:NM4
52 GF Score
Price €0.24
GF Value €0.51
! 5 Warning Signs
View Full Analysis

What is Vimab Group AB Common Stock?

Vimab Group AB FRA:NM4 -3.19% 52 Common Stock is €0.88 Mil as of Mar. 2026. GuruFocus rates FRA:NM4 with a GF Score™ of 52/100 and a GF Value™ of €0.51. The stock has 5 warning signs investors should review.

Vimab Group AB's quarterly common stock increased from Sep. 2025 (€0.48 Mil) to Dec. 2025 (€0.49 Mil) and increased from Dec. 2025 (€0.49 Mil) to Mar. 2026 (€0.88 Mil).

Vimab Group AB's annual common stock increased from Dec. 2023 (€0.40 Mil) to Dec. 2024 (€0.42 Mil) and increased from Dec. 2024 (€0.42 Mil) to Dec. 2025 (€0.49 Mil).

Vimab Group AB Common Stock Historical Data

* Premium members only.

The historical data trend for Vimab Group AB's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimab Group AB Common Stock Chart

Vimab Group AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.02 0.35 0.40 0.42 0.49

Vimab Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.48 0.48 0.49 0.88
FRA:NM4
52GF Score
Vimab Group AB FRA:NM4
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vimab Group AB Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €0.88 Mil mean?
Vimab Group AB (FRA:NM4) has a Common Stock of €0.88 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Vimab Group AB and its competitors.
Is Vimab Group AB's Common Stock too high?
Vimab Group AB's current Common Stock is €0.88 Mil. Overall, Vimab Group AB has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Vimab Group AB's Common Stock compare to VRSK and EFX?
Vimab Group AB's Common Stock of €0.88 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Business Services company?
A good Common Stock depends on the Business Services industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Vimab Group AB and its competitors. Vimab Group AB's current Common Stock is €0.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimab Group AB stock overvalued right now?
Vimab Group AB (FRA:NM4) has a current Common Stock of €0.88 Mil. The stock's GF Value™ is €0.51, compared to a current price of €0.24 — trading 52.4% below its estimated fair value. The current Common Stock is €0.88 Mil. Vimab Group AB's overall GF Score™ is 52/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Vimab Group AB (FRA:NM4), the current Common Stock is €0.88 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimab Group AB (FRA:NM4) Overvalued in 2026?

Based on GuruFocus' analysis, Vimab Group AB stock appears to be undervalued. The current stock price of €0.24 is trading 52.4% below its estimated GF Value™ of €0.51.

Key valuation signals for FRA:NM4:

  • Common Stock: €0.88 Mil
  • GF Value™: €0.51 vs. price of €0.24 (52.4% below fair value)
  • GF Score™: 52/100 with 5 warning signs

No single metric tells the full story. See the FRA:NM4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vimab Group AB Business Description

Other Exchanges VIMAB:Sweden
Address Malmskillnadsgatan 40A, Stockholm, SWE, 111 57
Vimab Group AB is a Nordic company helping companies with transformation and improvement initiatives. It offers services including Interim management, Executive search.
52GF Score

Get the complete analysis for FRA:NM4

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.24
Price
€0.51
GF Value